Scale weight and body composition are different measurements
Most large trials report change in total body weight, because it is cheap and reliable to measure. Body composition — the split between fat mass and fat-free mass — requires DEXA, hydrostatic weighing, or similar, and is measured in a minority of studies.
This is why a trial can report substantial weight change while saying nothing directly about what happened to fat versus lean tissue. When a summary describes a change in fat mass from a study that measured only body weight, the summary has added something the study did not report.
Regional fat distribution: what the evidence supports
Where fat is lost from is substantially determined by factors an individual does not control, including genetics, sex, and hormonal environment. Controlled studies of targeted training have generally not found a meaningful preferential reduction in fat mass at the trained region.
Abdominal fat specifically has been studied a great deal because visceral fat carries metabolic significance. But 'this intervention reduced visceral fat on average across a group' is a different statement from 'this will reduce fat where you want it', and the second does not follow from the first.
Adaptive responses to sustained deficit
Extended energy restriction is accompanied by measurable adaptations: reduced non-exercise activity, changes in appetite-regulating signalling, and a decline in energy expenditure somewhat beyond what the smaller body mass alone predicts.
These responses are well documented and they make the later stages of a deficit genuinely harder than the early ones. A plateau after months of restriction is a predictable physiological response and not evidence of a metabolic defect.
What the incretin trials measured
The large incretin trials summarised in this site's study library — the STEP and SURMOUNT programmes among them — used percent change in body weight as their primary endpoint, in specific populations, with defined inclusion criteria, over defined durations.
Reading them well means reading the population and the endpoint, not the headline percentage. Effects observed in a trial population that met specific criteria do not automatically describe what happens outside those criteria, and the trials were not designed to answer questions about regional composition.
What this research does not establish
- Trials measuring body weight did not measure body composition; the two are not interchangeable.
- Controlled research has not supported targeted regional reduction in fat mass from training a specific area.
- Trial results describe averages in defined populations under defined conditions, and individual variation within those trials was wide.
Common questions
- Why am I losing weight but not belly fat?
- Where fat is mobilised from is largely determined by genetics, sex, and hormonal environment rather than by which area is trained or targeted. Controlled studies of targeted training have generally not found a meaningful preferential reduction in fat mass at the trained region. Scale weight can therefore change while regional distribution changes little.
- I'm eating right and exercising and still can't lose belly fat — is something wrong?
- Not necessarily. Sustained energy restriction produces documented adaptations — reduced spontaneous activity, changes in appetite signalling, and lower total energy expenditure than body mass alone predicts — which make later stages harder than early ones. A plateau after months of restriction is a predictable response rather than evidence of a defect.
- What is a body recomposition plateau?
- Informally, the point at which fat mass and fat-free mass both stop changing despite consistent training and intake. It is not a defined term in the research literature, which is one reason claims about it are hard to evaluate — there is no standard endpoint being measured across studies.
- Did the major incretin trials measure fat mass specifically?
- Mostly no. The large incretin trials used percent change in total body weight as the primary endpoint. Body composition requires DEXA or similar and was assessed in a minority of studies, so summaries describing 'reduction in fat mass' from those trials are generally adding an interpretation the trial did not report.